FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
ATHENAHEALTH INC [ ATHN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year)
09/25/2007 |
||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 09/25/2007 | C | 4,457,942 | A | $0 | 4,457,942 | I | See Footnote. ( 1 ) | ||
Common Stock | 09/25/2007 | C | 47,512 | A | $0 | 47,512 | I | See Footnote. ( 2 ) | ||
Common Stock | 09/25/2007 | C | 107,004 | A | $0 | 107,004 | I | See Footnote. ( 3 ) | ||
Common Stock | 09/25/2007 | S | 445,795 ( 4 ) | D | $18 | 4,012,147 | I | See Footnote. ( 1 ) | ||
Common Stock | 09/25/2007 | S | 4,751 ( 4 ) | D | $18 | 42,761 | I | See Footnote. ( 2 ) | ||
Common Stock | 09/25/2007 | S | 10,700 ( 4 ) | D | $18 | 96,304 | I | See Footnote. ( 3 ) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Series A-1 preferred stock | ( 5 ) | 09/25/2007 | C | 82,153 | 09/25/2007 | ( 6 ) | Common Stock | 82,153 | ( 5 ) | 0 | I | See Footnote. ( 1 ) | |||
Series A-1 preferred stock | ( 5 ) | 09/25/2007 | C | 875 | 09/25/2007 | ( 6 ) | Common Stock | 875 | ( 5 ) | 0 | I | See Footnote. ( 2 ) | |||
Series A-1 preferred stock | ( 5 ) | 09/25/2007 | C | 1,972 | 09/25/2007 | ( 6 ) | Common Stock | 1,972 | ( 5 ) | 0 | I | See Footnote. ( 3 ) | |||
Series D preferred stock | ( 5 ) | 09/25/2007 | C | 4,207,013 | 09/25/2007 | ( 6 ) | Common Stock | 4,207,013 | ( 5 ) | 0 | I | See Footnote. ( 1 ) | |||
Series D preferred stock | ( 5 ) | 09/25/2007 | C | 44,839 | 09/25/2007 | ( 6 ) | Common Stock | 44,839 | ( 5 ) | 0 | I | See Footnote. ( 2 ) | |||
Series D preferred stock | ( 5 ) | 09/25/2007 | C | 100,980 | 09/25/2007 | ( 6 ) | Common Stock | 100,980 | ( 5 ) | 0 | I | See Footnote. ( 3 ) | |||
Series E preferred stock | ( 5 ) | 09/25/2007 | C | 168,776 | 09/25/2007 | ( 6 ) | Common Stock | 168,776 | ( 5 ) | 0 | I | See Footnote. ( 1 ) | |||
Series E preferred stock | ( 5 ) | 09/25/2007 | C | 1,798 | 09/25/2007 | ( 6 ) | Common Stock | 1,798 | ( 5 ) | 0 | I | See Footnote. ( 2 ) | |||
Series E preferred stock | ( 5 ) | 09/25/2007 | C | 4,052 | 09/25/2007 | ( 6 ) | Common Stock | 4,052 | ( 5 ) | 0 | I | See Footnote. ( 3 ) |
Explanation of Responses: |
1. Represents shares directly owned by Oak Investment Partners IX, L.P. ("Oak IX, L.P."). |
2. Represents shares directly owned by Oak IX Affiliates Fund, L.P. ("Oak IX Affiliates, L.P."). |
3. Represents shares owned directly by Oak IX Affiliates Fund-A, L.P. ("Oak IX Affiliates A, L.P."). |
4. Shares sold pursuant to the initial public offering of common stock of athenahealth, Inc. through both the secondary offering and exercise of the over-allotment option by the underwriters. |
5. These shares automatically converted into common stock on a one-for-one basis upon the closing of the Issuer's initial public offering of common stock. |
6. The preferred stock has no expiration date. |
Remarks: |
Ann H. Lamont is a director of athenahealth, Inc. Ms. Lamont is a Managing Member of Oak Associates IX, L.L.C., the General Partner of Oak IX, L.P.; and a Managing Member of Oak IX Affiliates, L.L.C., the General Partner of Oak IX Affiliates, L.P. and Oak IX Affiliates A , L.P. Ms. Lamont disclaims beneficial ownership of any securities (except to the extent of her pecuniary interest in such securities), and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of any such securities for purposes of Section 16 or for any other purpose. |
/s/ Christopher E. Nolin Attorney-in-Fact | 09/25/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |